In a neonate or young infant, especially with a large patent ductus arteriosus, severe sepsis, metabolic disease, or congenital liver anomaly, how can I recognize acute liver failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recognizing Acute Liver Failure in Neonates and Young Infants

Acute liver failure in a baby is identified primarily by the presence of coagulopathy (prolonged PT/INR) that persists after vitamin K administration, even when transaminases or bilirubin levels appear near normal or only mildly elevated. 1, 2

Critical Diagnostic Features

Primary Laboratory Indicators

  • Coagulopathy is the cardinal finding: Prothrombin time (PT/INR) prolongation after vitamin K administration defines acute liver failure in infants, as loss of >70% of hepatic synthetic function produces clinically significant coagulopathy 3, 2, 4

  • Transaminases can be misleadingly normal: In neonatal hemochromatosis and tyrosinemia, transaminases may be low or near normal despite severe liver failure, whereas hypoxic-ischemic injury and infections typically produce markedly elevated transaminases 1, 5

  • Conjugated hyperbilirubinemia >25 μmol/L requires urgent referral: Any neonate with conjugated bilirubin exceeding this threshold needs immediate pediatric assessment for liver disease 3

  • Jaundice may be absent: Up to 24% of infants with acute liver failure present without visible jaundice, making coagulopathy screening essential in any sick neonate 1

Clinical Presentation Patterns

High-risk scenarios demanding immediate evaluation:

  • Sepsis with coagulopathy: Severe infection can precipitate acute liver failure through direct hepatocellular injury 1, 2

  • Large patent ductus arteriosus with poor perfusion: Hypoxic-ischemic insult accounts for 19% of neonatal acute liver failure cases and produces elevated transaminases with coagulopathy 1

  • Failure to thrive with hepatomegaly: Progressive hepatosplenomegaly, ascites, and synthetic dysfunction suggest metabolic disease (36% of cases) or alpha-1 antitrypsin deficiency 3, 1

  • Acholic stools with dark urine: Biliary atresia represents 50% of neonatal cholestasis and requires surgical intervention before 60 days of age 6

Essential Immediate Workup

Obtain these tests urgently in any infant with suspected liver failure:

  • Fractionated bilirubin (total and conjugated)
  • Complete blood count with platelet count
  • PT/INR and PTT after vitamin K administration
  • Serum transaminases (AST, ALT)
  • Albumin
  • Blood glucose 3, 6, 1

Thrombocytopenia indicates advanced disease: Low platelets result from decreased production, splenic sequestration, and increased destruction in severe liver injury 3

Etiology-Specific Recognition Patterns

Metabolic Disease (36% of cases)

  • Tyrosinemia Type 1: Elevated AFP (often 10-fold above normal neonatal range), coagulopathy appearing before other hepatic signs, and systemic illness; diagnosis requires elevated blood/urine succinylacetone 6, 1

  • Galactosemia: Start lactose-free feeding immediately until excluded, as this is life-saving treatment 2, 5

  • Alpha-1 antitrypsin deficiency: Neonatal cholestasis with hepatomegaly; perform phenotyping by isoelectric focusing in all infants with conjugated hyperbilirubinemia 3, 6

Neonatal Hemochromatosis (9% of cases)

  • Leading cause of acute liver failure requiring transplantation in neonates
  • Presents within first days of life with severe hepatic injury and iron overload
  • Characterized by low or near-normal transaminases despite profound synthetic dysfunction 6, 1

Infection (17% of cases)

  • Start acyclovir immediately until herpes simplex virus infection is excluded, as this is life-saving treatment 2
  • Viral infections typically produce high transaminases and coagulopathy 1

Critical Management Steps

Immediate actions upon recognition:

  1. Urgent referral to pediatric liver transplant center is mandatory for any neonate with acute liver failure or acute decompensation 6, 4

  2. Initiate empiric acyclovir until HSV excluded 2

  3. Switch to lactose-free feeding until galactosemia excluded 2, 5

  4. Correct coagulopathy with fresh frozen plasma and vitamin K 1

  5. Monitor for hypoglycemia every 2-4 hours, as encephalopathy in neonates usually reflects specific metabolic derangements rather than hepatic encephalopathy 5

Common Pitfalls to Avoid

  • Do not rely on transaminase levels alone: Normal or mildly elevated transaminases do not exclude severe liver failure in neonates 1, 5

  • Do not wait for jaundice: One-quarter of infants with acute liver failure lack visible jaundice at presentation 1

  • Do not delay transplant referral: Mortality remains 40-50% despite intensive care, and early contact with transplant centers improves outcomes 1, 4

  • Do not overlook conjugated bilirubin: In neonates with any jaundice, always fractionate bilirubin, as conjugated hyperbilirubinemia indicates parenchymal liver disease requiring urgent evaluation 3, 7

References

Research

Liver Failure in Early Infancy: Aetiology, Presentation, and Outcome.

Journal of pediatric gastroenterology and nutrition, 2017

Research

Acute liver failure in newborns.

Turkish archives of pediatrics, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Inborn errors presenting with liver dysfunction.

Seminars in neonatology : SN, 2002

Guideline

Diagnostic Evaluation of Neonatal Liver Failure with Elevated AFP and Positive Direct Coombs Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Neonatal Unconjugated Hyperbilirubinemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.